BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24210187)

  • 1. Melanoma incidence rises for children and adolescents: an epidemiologic review of pediatric melanoma in the United States.
    Austin MT; Xing Y; Hayes-Jordan AA; Lally KP; Cormier JN
    J Pediatr Surg; 2013 Nov; 48(11):2207-13. PubMed ID: 24210187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006.
    Jemal A; Saraiya M; Patel P; Cherala SS; Barnholtz-Sloan J; Kim J; Wiggins CL; Wingo PA
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S17-25.e1-3. PubMed ID: 22018063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in incidence of primary cutaneous malignancies in children, adolescents, and young adults: a population-based study.
    Senerchia AA; Ribeiro KB; Rodriguez-Galindo C
    Pediatr Blood Cancer; 2014 Feb; 61(2):211-6. PubMed ID: 24174376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma Incidence in Children and Adolescents: Decreasing Trends in the United States.
    Campbell LB; Kreicher KL; Gittleman HR; Strodtbeck K; Barnholtz-Sloan J; Bordeaux JS
    J Pediatr; 2015 Jun; 166(6):1505-13. PubMed ID: 25866386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.
    Shaikh WR; Weinstock MA; Halpern AC; Oliveria SA; Geller AC; Dusza SW
    Cancer Epidemiol; 2013 Feb; 37(1):64-70. PubMed ID: 22995853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study.
    McAteer JP; Huaco JA; Gow KW
    J Pediatr Surg; 2013 May; 48(5):1025-31. PubMed ID: 23701777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
    Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
    Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial Spreading Melanomas in Children: An Analysis of Outcomes Using the Surveillance, Epidemiology, and End Results (SEER) Database.
    Allan BJ; Ovadia S; Tashiro J; Thaller SR
    Ann Plast Surg; 2015 Sep; 75(3):327-31. PubMed ID: 24667880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant melanoma incidence among children and adolescents in Texas and SEER 13, 1995-2013.
    Danysh HE; Navai SA; Scheurer ME; Hunt R; Venkatramani R
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27648. PubMed ID: 30729662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Specific Incidence of Melanoma in the United States.
    Paulson KG; Gupta D; Kim TS; Veatch JR; Byrd DR; Bhatia S; Wojcik K; Chapuis AG; Thompson JA; Madeleine MM; Gardner JM
    JAMA Dermatol; 2020 Jan; 156(1):57-64. PubMed ID: 31721989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of thick melanomas in the United States: beware of the nodular subtype.
    Demierre MF; Chung C; Miller DR; Geller AC
    Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous melanoma in childhood and adolescence.
    Hamre MR; Chuba P; Bakhshi S; Thomas R; Severson RK
    Pediatr Hematol Oncol; 2002; 19(5):309-17. PubMed ID: 12078862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of childhood and adolescent melanoma in the United States: 1973-2009.
    Wong JR; Harris JK; Rodriguez-Galindo C; Johnson KJ
    Pediatrics; 2013 May; 131(5):846-54. PubMed ID: 23589817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thick melanoma: the challenge persists.
    Murray CS; Stockton DL; Doherty VR
    Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and sex differences for malignant melanoma in the pediatric population-childhood versus adolescence: analysis of current nationwide data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program.
    Kelm RC; Ali Y; Orrell K; Rangel SM; Kruse L; Wagner AM; Gerami P; West DP; Nardone B
    J Am Acad Dermatol; 2021 Mar; 84(3):862-864. PubMed ID: 33478777
    [No Abstract]   [Full Text] [Related]  

  • 16. Melanoma surveillance in the United States: overview of methods.
    Watson M; Johnson CJ; Chen VW; Thomas CC; Weir HK; Sherman R; Cockburn M; Jackson-Thompson J; Saraiya M
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S6-16. PubMed ID: 22018069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base.
    Lange JR; Palis BE; Chang DC; Soong SJ; Balch CM
    J Clin Oncol; 2007 Apr; 25(11):1363-8. PubMed ID: 17416855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant blue nevus: clinicopathologically similar to melanoma.
    Kachare SD; Agle SC; Englert ZP; Zervos EE; Vohra NA; Wong JH; Fitzgerald TL
    Am Surg; 2013 Jul; 79(7):651-6. PubMed ID: 23815995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
    Criscione VD; Weinstock MA
    Arch Dermatol; 2007 Jul; 143(7):854-9. PubMed ID: 17638728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetime risks of cutaneous melanoma by histological subtype and race/ethnicity in the United States.
    Feng Z; Zhang Z; Wu XC
    J La State Med Soc; 2013; 165(4):201-8. PubMed ID: 24133782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.